Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;23(3):468-476.
doi: 10.3201/eid2303.161927.

Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013

Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013

Theodore K Marras et al. Emerg Infect Dis. 2017 Mar.

Abstract

Survival implications of nontuberculous mycobacterial pulmonary disease (NTM-PD) and NTM pulmonary isolation without disease (NTM-PI) are unclear. To study deaths associated with NTM-PD and NTM-PI and differences in survival between them, we conducted a population-based cohort study of persons with microbiologically defined NTM-PD or NTM-PI diagnosed during 2001-2013 in Ontario, Canada. We used propensity score matching and Cox proportional hazards models to compare survival. Among 9,681 NTM-PD patients and 10,936 NTM-PI patients, 87% and 91%, respectively, were successfully matched with unexposed controls. Both NTM-PD and NTM-PI were associated with higher rates of death for all species combined and for most individual species. Compared with NTM-PI, NTM-PD was associated with higher death rates for all species combined, Mycobacterium avium complex, and M. xenopi. NTM-PD and NTM-PI were significantly associated with death, NTM-PD more so than NTM-PI.

Keywords: Canada; Mycobacterium abscessus; Mycobacterium avium complex; Mycobacterium fortuitum; Mycobacterium kansasii; Mycobacterium xenopi; Ontario; Tuberculosis and other mycobacteria; bacteria; mortality; nontuberculous mycobacteria; survival.

PubMed Disclaimer

Figures

Figure
Figure
Kaplan-Meier survival curves for any pulmonary NTM isolation, by species group, Ontario, Canada, 2001–2013. Curve comprises all matched and unmatched patients identified during the study period. There is a statistically significant difference among curves (p<0.001, log-rank) in crude survival comparison, uncontrolled for any other variables. Differences between individual species pairs statistically significant (p<0.00005) for all pairs except Mycobacterium abscessus versus M. fortuitum (p = 0.19), M. abscessus versus Mycobacterium avium complex (p = 0.14), and M. fortuitum versus Mycobacterium avium complex (MAC) (p = 0.50).

References

    1. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013;19:1889–91. 10.3201/eid1911.130737 - DOI - PMC - PubMed
    1. Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12:642–7. 10.1513/AnnalsATS.201412-559OC - DOI - PMC - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881–6. 10.1164/rccm.201111-2016OC - DOI - PMC - PubMed
    1. Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105:1718–25. 10.1016/j.rmed.2011.08.004 - DOI - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. [Erratum in: Am J Respir Crit Care Med. 2007;175:744–5]. Am J Respir Crit Care Med. 2007;175:367–416. 10.1164/rccm.200604-571ST - DOI - PubMed

Publication types